Rye Brook Capital’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-23,100
Closed -$3.13M 28
2021
Q1
$3.13M Buy
23,100
+4,900
+27% +$665K 2.28% 16
2020
Q4
$2.56M Buy
+18,200
New +$2.56M 2.23% 16